# OnCo record paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014" ;
  schema:name "FoRT: 4 Gy versus 24 Gy radiotherapy for indolent lymphoma, a randomised phase 3 non-inferiority trial"@en ;
  schema:description "Two small doses of radiotherapy did not control follicular and marginal zone lymphoma as well as the standard twelve, with more than three times the rate of regrowth in the treated area, so 24 Gy remains the standard and 4 Gy is for palliation."@en ;
  schema:url <https://onco.cc/key-papers/paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(14)70036-1>, <https://pubmed.ncbi.nlm.nih.gov/24572077/> ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(14)70036-1> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Hoskin PJ, Kirkwood AA, Popova B, et al." ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/> ;
  onco:trials <https://onco.cc/trials/fort/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .